Acetaminophen-induced hepatic neutrophil accumulation and inflammatory liver injury in CD18-deficient mice
Authors:
- 26 May 2010
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 30 (9) , 1280-1292
Abstract
Background: Acetaminophen (APAP) hepatotoxicity is currently the most frequent cause of acute liver failure in the US and many European countries. Although intracellular signalling mechanisms are critical for hepatocellular injury, a contribution of inflammatory cells, especially neutrophils, has been suggested. However, conflicting results were obtained when using immunological intervention strategies. Aims: The role of neutrophils was investigated using a CD18‐deficient mouse model. Results: Treatment of C57Bl/6 wild type mice with 300 mg/kg APAP resulted in severe liver cell necrosis at 12 and 24 h. This injury was accompanied by formation of cytokines and chemokines and accumulation of neutrophils in the liver. However, there was no difference in the inflammatory response or liver injury in CD18‐deficient mice compared with wild‐type animals. In contrast to treatment with endotoxin, no upregulation of CD11b or priming for reactive oxygen was observed on neutrophils isolated from the peripheral blood or the liver after APAP administration. Furthermore, animals treated with endotoxin 3 h after APAP experienced an exaggerated inflammatory response as indicated by substantially higher cytokine and chemokine formation and twice the number of neutrophils in the liver. However, liver injury in the two‐hit model was the same as with APAP alone. Conclusions: Our data do not support the hypothesis that neutrophils contribute to APAP hepatotoxicity or that a neutrophil‐mediated injury phase could be provoked by a second, pro‐inflammatory hit. Thus, APAP‐induced liver injury in mice is dominated by intracellular mechanisms of cell death rather than by neutrophilic inflammation.Keywords
This publication has 57 references indexed in Scilit:
- CD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune ResponsesScience, 2009
- Simvastatin protects against cholestasis‐induced liver injuryBritish Journal of Pharmacology, 2009
- Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasomeJournal of Clinical Investigation, 2009
- Plasminogen Activator Inhibitor-1 Limits Liver Injury and Facilitates Regeneration after Acetaminophen OverdoseToxicological Sciences, 2008
- Neutrophil depletion protects against murine acetaminophen hepatotoxicity: Another perspectiveHepatology, 2007
- ANIT toxicity toward mouse hepatocytes in vivo is mediated primarily by neutrophils via CD18American Journal of Physiology-Gastrointestinal and Liver Physiology, 2006
- Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditionsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2006
- Opposite roles of neutrophils and macrophages in the pathogenesis of acetaminophen‐induced acute liver injuryEuropean Journal of Immunology, 2006
- Neutrophils Aggravate Acute Liver Injury During Obstructive Cholestasis in Bile Duct-Ligated MiceHepatology, 2003
- Role of Neutrophils in Hepatotoxicity Induced by Oral Acetaminophen Administration in RatsJournal of Surgical Research, 1998